Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy M Finke

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|April 9, 2015
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemiaMichelle A Elliott, Animesh Pardanani, Curtis A Hanson, et al.
American Journal of Hematology|August 29, 2018
Mutations and karyotype predict treatment response in myelodysplastic syndromesDame Idossa, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|December 6, 2018
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosisAyalew Tefferi, Terra L Lasho, Mythri Mudireddy, et al.
Blood|September 13, 2012
SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survivalTerra L Lasho, Thitina Jimma, Christy M Finke, et al.
Blood Advances|January 4, 2018
Targeted deep sequencing in primary myelofibrosisAyalew Tefferi, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|October 13, 2016
DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemiaMrinal M Patnaik, Daniela Barraco, Terra L Lasho, et al.
American Journal of Hematology|July 15, 2017
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevanceRangit Vallapureddy, Terra L Lasho, Katherine Hoversten, et al.
American Journal of Hematology|February 15, 2016
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencingMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|March 9, 2018
U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlatesAyalew Tefferi, Mythri Mudireddy, Christy M Finke, et al.
American Journal of Hematology|August 15, 2018
Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patientsPrateek Pophali, Pedro Horna, Terra L Lasho, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|April 9, 2015
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemiaMichelle A Elliott, Animesh Pardanani, Curtis A Hanson, et al.
American Journal of Hematology|August 29, 2018
Mutations and karyotype predict treatment response in myelodysplastic syndromesDame Idossa, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|December 6, 2018
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosisAyalew Tefferi, Terra L Lasho, Mythri Mudireddy, et al.
Blood|September 13, 2012
SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survivalTerra L Lasho, Thitina Jimma, Christy M Finke, et al.
Blood Advances|January 4, 2018
Targeted deep sequencing in primary myelofibrosisAyalew Tefferi, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|October 13, 2016
DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemiaMrinal M Patnaik, Daniela Barraco, Terra L Lasho, et al.
American Journal of Hematology|July 15, 2017
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevanceRangit Vallapureddy, Terra L Lasho, Katherine Hoversten, et al.
American Journal of Hematology|February 15, 2016
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencingMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|March 9, 2018
U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlatesAyalew Tefferi, Mythri Mudireddy, Christy M Finke, et al.
American Journal of Hematology|August 15, 2018
Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patientsPrateek Pophali, Pedro Horna, Terra L Lasho, et al.
Pageof 7